Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Tegretol-XR launched in U.S.

Aug. 30, 1996

No Comments

CGP-25454 tested in healthy volunteers

Aug. 30, 1996

No Comments

Correlation established between serum PLA2 activity and schizophrenia symptoms

Aug. 30, 1996

No Comments

Potential antipsychotic described by Parke-Davis

Aug. 30, 1996

No Comments

Famotidine tested in schizophrenic patients

Aug. 30, 1996

No Comments

DuPont Merck reports on CRH antagonists for anxiety, depression

Aug. 30, 1996

No Comments

Russian investigators describe new tranquilizer

Aug. 30, 1996

No Comments

BMS, Sano to collaborate on transdermal BuSpar development

Aug. 30, 1996

No Comments

Flunitrazepam may alter circadian sleep-wake rhythms

Aug. 30, 1996

No Comments

Merck & Co. reports NK1 antagonists

Aug. 30, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Neurology/psychiatric
RSS

Tegretol-XR launched in U.S.

CGP-25454 tested in healthy volunteers

Correlation established between serum PLA2 activity and schizophrenia symptoms

Potential antipsychotic described by Parke-Davis

Famotidine tested in schizophrenic patients

DuPont Merck reports on CRH antagonists for anxiety, depression

Russian investigators describe new tranquilizer

BMS, Sano to collaborate on transdermal BuSpar development

Flunitrazepam may alter circadian sleep-wake rhythms

Merck & Co. reports NK1 antagonists

Today's news in brief

Today's news in brief

J&J’s Ottava robotic system approved for US pivotal trial

In muscular dystrophies, gene therapies race the clock

‘Evo’ AI can design complete genomes

Neurology/psychiatric RSS

Neurology/psychiatric
RSS